Trial · NCT02173379
Trial comparisons166
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
41 to 60 of 166
Download this page as JSON| Comparison | Source |
|---|---|
| Absorb BVS vs XIENCE: Number of Participants With Rehospitalization | Trial comparisons |
| Absorb BVS vs XIENCE: TLF at 1-year, Non-inferiority Against the Control | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants Experienced Cardiac Death/All MI/ID-TLR/ID-TVR, Non TL (TVF) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants withTarget Lesion Revascularization (TLR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Repeat Coronary Arteriography | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Rehospitalization | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants Experienced Cardiac Death/All MI/ID-TLR/ID-TVR, Non TL (TVF) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Target Vessel Myocardial Infarction (TV-MI) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants Experienced Cardiac Death/All MI/ID-TLR/ID-TVR, Non TL (TVF) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants Experienced All Death/All MI | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants Experienced Death/All MI/All Revascularization (DMR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants Experienced Death/All MI/All Revascularization (DMR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Ischemia Driven TLR (ID-TLR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With ID-TVR Excluding TLR | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants Experienced Cardiac Death/All MI/ID-TLR (MACE) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Ischemia Driven TLR (ID-TLR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With All Coronary Revascularization | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With ID-TVR Excluding TLR | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Target Lesion Revascularization (TLR) | Trial comparisons |
| Absorb BVS vs XIENCE: Number of Participants With Myocardial Infarction (MI) | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02173379/comparisons?page=3